Status
Conditions
Treatments
About
Insomnia is a common sleep problem, which affects 9.4-38.2% of youths worldwide. Youth insomnia is linked to mental health problems, leading to substantial health and economic burden. The project aims to conduct an assessor-blind, randomized controlled trial to evaluate the efficacy of an app-based CBT-I with AI chatbot in reducing insomnia symptoms among youths, compared to an app-based CBT-I without AI chatbot.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
i. Youth aged 18 to 25 years (as defined by WHO and evidence on AI mental health chatbots only available for individuals aged 18 years and older)
ii. Online informed consent of participation in the study should be provided
iii. Willing to comply with the requirements of the study protocol
iv. The presence of moderate to severe insomnia measured by a score of 15 or above on the Insomnia Severity Index (ISI)
v. difficulties initiating, maintaining or nonrestorative sleep over a 1-month period
vi. Having access to a smartphone and consistent internet access for their smartphone
vii. Accepting the terms of service and privacy policies of the mobile apps used in the study for the delivery of the intervention
Exclusion criteria
i. A history of any sleep disorder(s) (other than insomnia disorder) such as narcolepsy, obstructive sleep apnea, and restless legs syndrome
ii. A history of any mental retardation or neuropsychiatric disorder(s) (other than depression and anxiety disorders as they are the secondary outcomes) such as bipolar disorder, schizophrenia, and substance use disorder
iii. Presence of serious suicidality as evidenced by ideation with a plan or an attempt
iv. Receiving any pharmacological treatment (including sleep promoting agents)
v. Receiving any structured psychotherapy
vi. Having shiftwork and trans-meridian travel in the past 3 months and during the intervention
Primary purpose
Allocation
Interventional model
Masking
168 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal